Skip to main content
SpringerLink
Log in

„Multidrug resistance-associated proteins“ beim malignen Melanom

Molekularer Marker für die Therapie?

Multidrug resistance-associated proteins in malignant melanoma

Molecular markers for therapy

  • Gehört-Gelesen-Nachgefragt
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Baron JM, Höller D, Schiffer R et al (2001) Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116(4):541–548

    Article  PubMed  CAS  Google Scholar 

  2. Deeley RG, Westlake C, Cole SP (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86(3):849–899

    Article  PubMed  CAS  Google Scholar 

  3. Heimerl S, Bosserhoff AK, Langmann T et al (2007) Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res 17(5):265–273

    Article  PubMed  CAS  Google Scholar 

  4. Liedert B, Materna V, Schadendorf D et al (2003) Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin. J Invest Dermatol 121(1):172–176

    Article  PubMed  CAS  Google Scholar 

  5. Reid G, Wielinga P, Zelcer N et al (2003) The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA 100(16):9244–9249

    Article  PubMed  CAS  Google Scholar 

  6. Schadendorf D, Makki A, Stahr C et al (1995) Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 147(6):1545–1552

    PubMed  CAS  Google Scholar 

  7. Ugurel S (2008) Ex-vivo Chemosensitivitätstestung: Eine Strategie zur Realisierung einer individualisierten Therapie des metastasierten malignen Melanoms. Journal Onkologie, Zeitschrift online, Ausgabe 04-08

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Hautklinik, Universitätsklinikum der RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland

    A.F. Wendel, C. Skazik, H.F. Merk & J.M. Baron

Authors
  1. A.F. Wendel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Skazik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H.F. Merk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J.M. Baron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A.F. Wendel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wendel, A., Skazik, C., Merk, H. et al. „Multidrug resistance-associated proteins“ beim malignen Melanom. Hautarzt 60, 250–252 (2009). https://doi.org/10.1007/s00105-008-1690-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-008-1690-0

Search

Navigation